Physician profile
Derrick Umansky
NPI 1104168541
$13,306.16
in general payments reported to CMS, 2019-2025
24 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $812 · 2021: $9,157 · 2022: $969 · 2023: $1,599 · 2024: $445 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461 · Travel and Lodging: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,461.19 |
| Travel and Lodging | $908.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $3,363.25 | 2021-2024 | Creo 5.5, Coalition Mis / Mis Ti, Creo Threaded |
| Medtronic, INC. | $3,332.52 | 2021-2025 | Unid_pass, O-Arm, Cd Horizon Spinal System |
| Alphatec Spine, INC | $2,505.67 | 2021 | |
| Integrity Implants INC. | $1,300.34 | 2021 | |
| Stryker Corporation | $660.87 | 2021 | |
| Boston Scientific Corporation | $475.80 | 2020-2022 | |
| Medtronic USA, INC. | $468.33 | 2020 | |
| Wenzel Spine, INC. | $170.63 | 2023 | Varilift |
| Spine Wave, INC. | $156.50 | 2020 | |
| Providence Medical Technology, INC. | $123.32 | 2025 | |
| Theragen, INC. | $119.82 | 2023 | Actastim-S |
| Astrazeneca Pharmaceuticals LP | $115.01 | 2023 | |
| Abbott Laboratories | $96.34 | 2021 | |
| Depuy Synthes Sales INC. | $91.01 | 2021 | |
| Alon Medical Technology | $69.85 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $52.08 | 2020 | |
| Spinal Elements, INC. | $44.39 | 2024 | |
| 4web, INC. | $40.05 | 2023 | Spine Truss System |
| Nevro Corp. | $30.57 | 2024 | Senza |
| Kuros Biosciences USA, INC | $27.99 | 2025 | Magnetos |
| Nalu Medical, INC. | $21.81 | 2024 | Nalu Neurostimulation System |
| Abbvie INC. | $16.29 | 2023 | Botox |
| Virtus Pharmaceuticals LLC | $16.02 | 2023 | Levorphanol Tartrate |
| Spineology INC. | $7.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Umansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.